(Reuters) -Advisers to the U.S. Food and Drug Administration will discuss whether to recommend COVID-19 vaccines for 2025-26 ...

Following President Trump's Most Favored Nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.

President Donald Trump put the biopharma industry on its back foot earlier this month with his executive order on ...

Under the program that was first announced by President Trump last week, the US would target prices based on benchmarks from ...

The U.S. Department of Health and Human Services (HHS) today announced immediate steps to implement President Trump’s ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The U.S. Department of Health and Human Services said on Tuesday it was setting most-favored-nation prescription drug pricing ...

Opinion: If Americans want to continue to have access to new life-saving and life-extending medications, someone will need to ...